(Q47849940)

6 February 2018

title

Apolipoprotein A-I mimetic peptide inhibits atherosclerosis by altering plasma metabolites in hypercholesterolemia (English)

1 reference

6 February 2018

0 references

1 reference

Zhi-Jun Ou

1

1 reference

6 February 2018

Li Li

2

1 reference

6 February 2018

Xiao-Long Liao

3

1 reference

6 February 2018

Yi-Ming Wang

4

1 reference

6 February 2018

Xiao-Xia Hu

5

1 reference

6 February 2018

Qing-Li Zhang

6

1 reference

6 February 2018

Zhi-Ping Wang

7

1 reference

6 February 2018

Huan Yu

8

1 reference

6 February 2018

Xi Zhang

9

1 reference

6 February 2018

Ping Hu

10

1 reference

6 February 2018

Ying-Qi Xu

11

1 reference

6 February 2018

Qiong-Lin Liang

12

1 reference

6 February 2018

Jing-Song Ou

13

1 reference

6 February 2018

Guoan Luo

14

1 reference

6 February 2018

publication date

24 April 2012

1 reference

6 February 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

6 February 2018

volume

303

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

E683-94

1 reference

6 February 2018

Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Shotgun lipidomics of neutral lipids as an enabling technology for elucidation of lipid-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabonomic study of Chinese medicine Shuanglong formula as an effective treatment for myocardial infarction in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Silent myocardial ischemia is associated with altered plasma phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Alteration of lysophosphatidylcholine content in low density lipoprotein after oxidative modification: relationship to endothelium dependent relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

LC-MS-based metabonomics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Ingenuity pathways analysis of urine metabonomics phenotypes toxicity of gentamicin in multiple organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Entry of polyunsaturated fatty acids into the brain: evidence that high-density lipoprotein-induced methylation of phosphatidylethanolamine and phospholipase A2 are involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Role of lysophosphatidylcholine (LPC) in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Apolipoprotein A-I mimetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

The role of dysfunctional HDL in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabonomics: a platform for studying drug toxicity and gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabolomic approaches to phenotype characterization and applications to complex diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

L-4F, an Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation in Hypercholesterolemia and Sickle Cell Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Simultaneous determination and quantification of seven major phospholipid classes in human blood using normal-phase liquid chromatography coupled with electrospray mass spectrometry and the application in diabetes nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

NMR-based prediction of cardiovascular risk in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabolomic identification of novel biomarkers of myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in dimethylnitrosamine treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Serum and urinary metabonomic study of human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Plasma fatty acids metabolic profiling analysis of coronary heart disease based on GC-MS and pattern recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

The Cardiovascular Risk of Healthy Individuals Studied by NMR Metabonomics of Plasma Samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00136.2012

10.1152/AJPENDO.00136.2012

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018